CA2515298C - Modified free-living microbes, vaccine compositions and methods of use thereof - Google Patents

Info

Publication number

CA2515298C

CA2515298C CA2515298A CA2515298A CA2515298C CA 2515298 C CA2515298 C CA 2515298C CA 2515298 A CA2515298 A CA 2515298A CA 2515298 A CA2515298 A CA 2515298A CA 2515298 C CA2515298 C CA 2515298C

Authority

CA

Canada

Prior art keywords

antigen

nucleic acid

microbe

listeria

disease

Prior art date

2003-02-06

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 229960005486 vaccine Drugs 0.000 title claims abstract description 224
• 238000000034 method Methods 0.000 title claims abstract description 96
• 239000000203 mixture Substances 0.000 title abstract description 63
• 108091007433 antigens Proteins 0.000 claims abstract description 433
• 102000036639 antigens Human genes 0.000 claims abstract description 433
• 239000000427 antigen Substances 0.000 claims abstract description 419
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 371
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 337
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 337
• 230000035772 mutation Effects 0.000 claims abstract description 238
• 210000000612 antigen-presenting cell Anatomy 0.000 claims abstract description 146
• 230000035755 proliferation Effects 0.000 claims abstract description 118
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 113
• 230000002238 attenuated effect Effects 0.000 claims abstract description 110
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 109
• 230000008439 repair process Effects 0.000 claims abstract description 65
• 208000015181 infectious disease Diseases 0.000 claims abstract description 37
• 208000035473 Communicable disease Diseases 0.000 claims abstract description 31
• 230000035800 maturation Effects 0.000 claims abstract description 20
• 238000011068 loading method Methods 0.000 claims abstract description 17
• 241000186781 Listeria Species 0.000 claims description 240
• 108090000623 proteins and genes Proteins 0.000 claims description 188
• 241000894006 Bacteria Species 0.000 claims description 169
• 150000001875 compounds Chemical class 0.000 claims description 152
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N furocoumarin Natural products C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 claims description 139
• 210000004027 cell Anatomy 0.000 claims description 130
• 201000010099 disease Diseases 0.000 claims description 108
• 230000028993 immune response Effects 0.000 claims description 89
• 230000014509 gene expression Effects 0.000 claims description 88
• 241000186779 Listeria monocytogenes Species 0.000 claims description 74
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 claims description 72
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 67
• 102000004169 proteins and genes Human genes 0.000 claims description 62
• 101150005573 uvrA gene Proteins 0.000 claims description 55
• 101150079601 recA gene Proteins 0.000 claims description 53
• 101150060445 uvrB gene Proteins 0.000 claims description 51
• -1 psoralen compound Chemical class 0.000 claims description 50
• 230000002950 deficient Effects 0.000 claims description 49
• 238000011282 treatment Methods 0.000 claims description 43
• 241000193738 Bacillus anthracis Species 0.000 claims description 39
• 229940065181 bacillus anthracis Drugs 0.000 claims description 34
• 238000006243 chemical reaction Methods 0.000 claims description 33
• 230000000694 effects Effects 0.000 claims description 33
• 101150023527 actA gene Proteins 0.000 claims description 32
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 31
• 238000000338 in vitro Methods 0.000 claims description 29
• 230000030741 antigen processing and presentation Effects 0.000 claims description 28
• 101150003576 uvrC gene Proteins 0.000 claims description 28
• 101150073340 uvrD gene Proteins 0.000 claims description 26
• 230000001939 inductive effect Effects 0.000 claims description 25
• 102000001218 Rec A Recombinases Human genes 0.000 claims description 20
• 108010055016 Rec A Recombinases Proteins 0.000 claims description 20
• 101150036926 phrB gene Proteins 0.000 claims description 20
• 208000023275 Autoimmune disease Diseases 0.000 claims description 17
• 101100385342 Synechocystis sp. (strain PCC 6803 / Kazusa) cry gene Proteins 0.000 claims description 17
• 239000003814 drug Substances 0.000 claims description 16
• 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims description 15
• 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims description 15
• 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims description 15
• 206010020751 Hypersensitivity Diseases 0.000 claims description 13
• 230000003213 activating effect Effects 0.000 claims description 13
• 238000004519 manufacturing process Methods 0.000 claims description 13
• 230000007815 allergy Effects 0.000 claims description 12
• 101001114052 Homo sapiens P antigen family member 4 Proteins 0.000 claims description 11
• 102100022430 Melanocyte protein PMEL Human genes 0.000 claims description 11
• 102100023240 P antigen family member 4 Human genes 0.000 claims description 11
• 101800001271 Surface protein Proteins 0.000 claims description 11
• 108010032166 TARP Proteins 0.000 claims description 11
• 239000012634 fragment Substances 0.000 claims description 11
• 101150046348 inlB gene Proteins 0.000 claims description 11
• 101150082315 spas-1 gene Proteins 0.000 claims description 11
• 102000004190 Enzymes Human genes 0.000 claims description 10
• 108090000790 Enzymes Proteins 0.000 claims description 10
• 102000003735 Mesothelin Human genes 0.000 claims description 10
• 108090000015 Mesothelin Proteins 0.000 claims description 10
• 239000002671 adjuvant Substances 0.000 claims description 9
• 208000026935 allergic disease Diseases 0.000 claims description 9
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims description 8
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims description 8
• 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 8
• 239000003937 drug carrier Substances 0.000 claims description 8
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 6
• 101000621309 Homo sapiens Wilms tumor protein Proteins 0.000 claims description 6
• 102100022748 Wilms tumor protein Human genes 0.000 claims description 6
• 230000007423 decrease Effects 0.000 claims description 6
• 230000002265 prevention Effects 0.000 claims description 6
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 5
• 125000004494 ethyl ester group Chemical group 0.000 claims description 5
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 5
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 4
• 101150084863 cya gene Proteins 0.000 claims description 4
• 101150005373 lef gene Proteins 0.000 claims description 4
• 230000001988 toxicity Effects 0.000 claims description 4
• 231100000419 toxicity Toxicity 0.000 claims description 4
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 claims description 3
• 101710113436 GTPase KRas Proteins 0.000 claims description 3
• 230000002163 immunogen Effects 0.000 claims description 3
• 208000027866 inflammatory disease Diseases 0.000 claims 6
• 230000001613 neoplastic effect Effects 0.000 claims 6
• 108091033319 polynucleotide Proteins 0.000 claims 2
• 102000040430 polynucleotide Human genes 0.000 claims 2
• 239000002157 polynucleotide Substances 0.000 claims 2
• 101710173814 UvrABC system protein A Proteins 0.000 claims 1
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims 1
• 239000003085 diluting agent Substances 0.000 claims 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
• 230000004913 activation Effects 0.000 abstract description 38
• 201000011510 cancer Diseases 0.000 abstract description 29
• 230000000813 microbial effect Effects 0.000 description 94
• 210000004443 dendritic cell Anatomy 0.000 description 78
• 241000699670 Mus sp. Species 0.000 description 72
• 229940115931 listeria monocytogenes Drugs 0.000 description 71
• 230000004048 modification Effects 0.000 description 61
• 238000012986 modification Methods 0.000 description 61
• 108010058846 Ovalbumin Proteins 0.000 description 58
• 229940092253 ovalbumin Drugs 0.000 description 57
• 230000001580 bacterial effect Effects 0.000 description 47
• 238000002255 vaccination Methods 0.000 description 39
• 235000018102 proteins Nutrition 0.000 description 38
• 238000012217 deletion Methods 0.000 description 37
• 230000037430 deletion Effects 0.000 description 37
• 239000013612 plasmid Substances 0.000 description 37
• 230000007939 microbial gene expression Effects 0.000 description 30
• 210000004989 spleen cell Anatomy 0.000 description 28
• 108020004414 DNA Proteins 0.000 description 24
• 108010076525 DNA Repair Enzymes Proteins 0.000 description 23
• 102000011724 DNA Repair Enzymes Human genes 0.000 description 23
• 230000027455 binding Effects 0.000 description 23
• 230000012010 growth Effects 0.000 description 22
• 230000010076 replication Effects 0.000 description 19
• 239000000523 sample Substances 0.000 description 19
• 230000003834 intracellular effect Effects 0.000 description 18
• 230000004044 response Effects 0.000 description 18
• 239000013598 vector Substances 0.000 description 18
• 239000002953 phosphate buffered saline Substances 0.000 description 17
• 101150030499 lnt gene Proteins 0.000 description 16
• 230000006870 function Effects 0.000 description 15
• 238000001727 in vivo Methods 0.000 description 15
• 210000001539 phagocyte Anatomy 0.000 description 15
• 230000002779 inactivation Effects 0.000 description 14
• 230000004083 survival effect Effects 0.000 description 14
• 230000008685 targeting Effects 0.000 description 14
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 13
• 230000020520 nucleotide-excision repair Effects 0.000 description 13
• 239000013615 primer Substances 0.000 description 13
• 239000011230 binding agent Substances 0.000 description 12
• 238000010790 dilution Methods 0.000 description 12
• 239000012895 dilution Substances 0.000 description 12
• 241000894007 species Species 0.000 description 12
• 239000001963 growth medium Substances 0.000 description 11
• 230000001225 therapeutic effect Effects 0.000 description 11
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• 241000700605 Viruses Species 0.000 description 10
• 241000607479 Yersinia pestis Species 0.000 description 10
• 238000003556 assay Methods 0.000 description 10
• 230000001717 pathogenic effect Effects 0.000 description 10
• 102000007469 Actins Human genes 0.000 description 9
• 108010085238 Actins Proteins 0.000 description 9
• 108091093088 Amplicon Proteins 0.000 description 9
• 235000003351 Brassica cretica Nutrition 0.000 description 9
• 235000003343 Brassica rupestris Nutrition 0.000 description 9
• 241000282414 Homo sapiens Species 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• 229960005091 chloramphenicol Drugs 0.000 description 9
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 9
• 238000011534 incubation Methods 0.000 description 9
• 235000010460 mustard Nutrition 0.000 description 9
• 230000000069 prophylactic effect Effects 0.000 description 9
• 210000000952 spleen Anatomy 0.000 description 9
• 210000001519 tissue Anatomy 0.000 description 9
• 239000003981 vehicle Substances 0.000 description 9
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
• 229930006000 Sucrose Natural products 0.000 description 8
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 230000001332 colony forming effect Effects 0.000 description 8
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 8
• 229940088598 enzyme Drugs 0.000 description 8
• 101150024289 hly gene Proteins 0.000 description 8
• 244000052769 pathogen Species 0.000 description 8
• 108090000765 processed proteins & peptides Proteins 0.000 description 8
• 230000005855 radiation Effects 0.000 description 8
• 230000009467 reduction Effects 0.000 description 8
• 239000005720 sucrose Substances 0.000 description 8
• 210000004881 tumor cell Anatomy 0.000 description 8
• 230000003612 virological effect Effects 0.000 description 8
• 229920000936 Agarose Polymers 0.000 description 7
• 238000011510 Elispot assay Methods 0.000 description 7
• 108010055196 EphA2 Receptor Proteins 0.000 description 7
• 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 7
• 241000233866 Fungi Species 0.000 description 7
• 230000006378 damage Effects 0.000 description 7
• 231100000673 dose–response relationship Toxicity 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• 238000004520 electroporation Methods 0.000 description 7
• 230000002458 infectious effect Effects 0.000 description 7
• 230000010354 integration Effects 0.000 description 7
• 210000000680 phagosome Anatomy 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
• 241000219198 Brassica Species 0.000 description 6
• 230000033616 DNA repair Effects 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 239000007995 HEPES buffer Substances 0.000 description 6
• 108091054437 MHC class I family Proteins 0.000 description 6
• 230000005867 T cell response Effects 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 6
• 238000001514 detection method Methods 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• 238000001502 gel electrophoresis Methods 0.000 description 6
• 230000002068 genetic effect Effects 0.000 description 6
• 230000003463 hyperproliferative effect Effects 0.000 description 6
• 239000007943 implant Substances 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 239000008188 pellet Substances 0.000 description 6
• 238000006116 polymerization reaction Methods 0.000 description 6
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
• 239000006228 supernatant Substances 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 229920001817 Agar Polymers 0.000 description 5
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 5
• 206010009944 Colon cancer Diseases 0.000 description 5
• 102000043129 MHC class I family Human genes 0.000 description 5
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
• 102100040247 Tumor necrosis factor Human genes 0.000 description 5
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 5
• 241000607734 Yersinia <bacteria> Species 0.000 description 5
• 239000008272 agar Substances 0.000 description 5
• 244000052616 bacterial pathogen Species 0.000 description 5
• 238000009566 cancer vaccine Methods 0.000 description 5
• 229940022399 cancer vaccine Drugs 0.000 description 5
• 239000006285 cell suspension Substances 0.000 description 5
• 229940125904 compound 1 Drugs 0.000 description 5
• 230000000875 corresponding effect Effects 0.000 description 5
• 238000000684 flow cytometry Methods 0.000 description 5
• 210000004408 hybridoma Anatomy 0.000 description 5
• 238000009169 immunotherapy Methods 0.000 description 5
• 239000000543 intermediate Substances 0.000 description 5
• 230000003211 malignant effect Effects 0.000 description 5
• 238000005259 measurement Methods 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 108091008819 oncoproteins Proteins 0.000 description 5
• 102000027450 oncoproteins Human genes 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 239000000047 product Substances 0.000 description 5
• 230000009870 specific binding Effects 0.000 description 5
• 230000002269 spontaneous effect Effects 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 238000011285 therapeutic regimen Methods 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 101150082952 ACTA1 gene Proteins 0.000 description 4
• 102100034452 Alternative prion protein Human genes 0.000 description 4
• 241000193830 Bacillus <bacterium> Species 0.000 description 4
• 102100039510 Cancer/testis antigen 2 Human genes 0.000 description 4
• 206010008631 Cholera Diseases 0.000 description 4
• 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 description 4
• 108700027766 Listeria monocytogenes hlyA Proteins 0.000 description 4
• 102000043131 MHC class II family Human genes 0.000 description 4
• 108091054438 MHC class II family Proteins 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 108091093078 Pyrimidine dimer Proteins 0.000 description 4
• 241000607142 Salmonella Species 0.000 description 4
• 241001664469 Tibicina haematodes Species 0.000 description 4
• 238000002835 absorbance Methods 0.000 description 4
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 238000010276 construction Methods 0.000 description 4
• 239000003431 cross linking reagent Substances 0.000 description 4
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 4
• 150000002148 esters Chemical class 0.000 description 4
• 230000036039 immunity Effects 0.000 description 4
• 230000003053 immunization Effects 0.000 description 4
• 238000002649 immunization Methods 0.000 description 4
• 229940031551 inactivated vaccine Drugs 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• 239000012678 infectious agent Substances 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 230000002503 metabolic effect Effects 0.000 description 4
• 229910052760 oxygen Inorganic materials 0.000 description 4
• 239000001301 oxygen Substances 0.000 description 4
• 230000003389 potentiating effect Effects 0.000 description 4
• 239000013635 pyrimidine dimer Substances 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 230000014616 translation Effects 0.000 description 4
• 238000005406 washing Methods 0.000 description 4
• UYYRDZGZGNYVBA-VPXCCNNISA-N (2s,3r,4s,5r,6r)-2-[2-chloro-4-[3-(3-chloro-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Cl)C(O)=CC=2)C=C1Cl UYYRDZGZGNYVBA-VPXCCNNISA-N 0.000 description 3
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 229940122450 Altered peptide ligand Drugs 0.000 description 3
• 241000219193 Brassicaceae Species 0.000 description 3
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 3
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 229930182566 Gentamicin Natural products 0.000 description 3
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 201000005702 Pertussis Diseases 0.000 description 3
• 108091000054 Prion Proteins 0.000 description 3
• 102100027192 Scavenger receptor class A member 3 Human genes 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 108010008038 Synthetic Vaccines Proteins 0.000 description 3
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
• ASJWEHCPLGMOJE-LJMGSBPFSA-N ac1l3rvh Chemical class N1C(=O)NC(=O)[C@@]2(C)[C@@]3(C)C(=O)NC(=O)N[C@H]3[C@H]21 ASJWEHCPLGMOJE-LJMGSBPFSA-N 0.000 description 3
• 230000003698 anagen phase Effects 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 230000006472 autoimmune response Effects 0.000 description 3
• 239000012472 biological sample Substances 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 230000001276 controlling effect Effects 0.000 description 3
• 238000004132 cross linking Methods 0.000 description 3
• 230000001472 cytotoxic effect Effects 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• 238000001962 electrophoresis Methods 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 201000006747 infectious mononucleosis Diseases 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 238000009830 intercalation Methods 0.000 description 3
• 230000002687 intercalation Effects 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 210000001165 lymph node Anatomy 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 230000004060 metabolic process Effects 0.000 description 3
• 210000001616 monocyte Anatomy 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 239000003642 reactive oxygen metabolite Substances 0.000 description 3
• 229940124551 recombinant vaccine Drugs 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 239000011550 stock solution Substances 0.000 description 3
• 229960005322 streptomycin Drugs 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 201000008827 tuberculosis Diseases 0.000 description 3
• 230000035899 viability Effects 0.000 description 3
• 230000007923 virulence factor Effects 0.000 description 3
• 239000000304 virulence factor Substances 0.000 description 3
• WEYNBWVKOYCCQT-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)NC1=CC=C(C)C(Cl)=C1 WEYNBWVKOYCCQT-UHFFFAOYSA-N 0.000 description 2
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
• 101710137115 Adenylyl cyclase-associated protein 1 Proteins 0.000 description 2
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
• 108010082126 Alanine transaminase Proteins 0.000 description 2
• 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
• 208000037259 Amyloid Plaque Diseases 0.000 description 2
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• 230000000970 DNA cross-linking effect Effects 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
• 101150029707 ERBB2 gene Proteins 0.000 description 2
• 241000991587 Enterovirus C Species 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 241000192125 Firmicutes Species 0.000 description 2
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
• 102100040578 G antigen 7 Human genes 0.000 description 2
• 230000005526 G1 to G0 transition Effects 0.000 description 2
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 2
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 2
• 101000893968 Homo sapiens G antigen 7 Proteins 0.000 description 2
• 101000576802 Homo sapiens Mesothelin Proteins 0.000 description 2
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000283160 Inia Species 0.000 description 2
• 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 2
• 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 2
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
• 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
• 108010054278 Lac Repressors Proteins 0.000 description 2
• 108700016271 Listeria monocytogenes actA Proteins 0.000 description 2
• 239000006137 Luria-Bertani broth Substances 0.000 description 2
• 208000016604 Lyme disease Diseases 0.000 description 2
• 231100000002 MTT assay Toxicity 0.000 description 2
• 238000000134 MTT assay Methods 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 2
• 201000009906 Meningitis Diseases 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 206010027458 Metastases to lung Diseases 0.000 description 2
• 108060004795 Methyltransferase Proteins 0.000 description 2
• 229930192392 Mitomycin Natural products 0.000 description 2
• 102100034256 Mucin-1 Human genes 0.000 description 2
• 102000016943 Muramidase Human genes 0.000 description 2
• 108010014251 Muramidase Proteins 0.000 description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
• 241000588653 Neisseria Species 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• 206010057249 Phagocytosis Diseases 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 206010035148 Plague Diseases 0.000 description 2
• 208000000474 Poliomyelitis Diseases 0.000 description 2
• 102100034937 Poly(A) RNA polymerase, mitochondrial Human genes 0.000 description 2
• 201000004681 Psoriasis Diseases 0.000 description 2
• LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 108091008874 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• 102100033082 TNF receptor-associated factor 3 Human genes 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 150000001251 acridines Chemical class 0.000 description 2
• 239000002168 alkylating agent Substances 0.000 description 2
• 229940037003 alum Drugs 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 150000004056 anthraquinones Chemical class 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000003302 anti-idiotype Effects 0.000 description 2
• 230000006023 anti-tumor response Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000007940 bacterial gene expression Effects 0.000 description 2
• 229960001212 bacterial vaccine Drugs 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 2
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 2
• 244000309466 calf Species 0.000 description 2
• 235000011089 carbon dioxide Nutrition 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 229940030156 cell vaccine Drugs 0.000 description 2
• 210000003850 cellular structure Anatomy 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 101150086784 cry gene Proteins 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 238000000502 dialysis Methods 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 108010070877 endodeoxyribonuclease uvrABC Proteins 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 229960002518 gentamicin Drugs 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 230000006801 homologous recombination Effects 0.000 description 2
• 238000002744 homologous recombination Methods 0.000 description 2
• 238000005286 illumination Methods 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• 230000009545 invasion Effects 0.000 description 2
• 230000005865 ionizing radiation Effects 0.000 description 2
• 239000004325 lysozyme Substances 0.000 description 2
• 229960000274 lysozyme Drugs 0.000 description 2
• 235000010335 lysozyme Nutrition 0.000 description 2
• 201000004792 malaria Diseases 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 229960004857 mitomycin Drugs 0.000 description 2
• 210000000822 natural killer cell Anatomy 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• IDBIFFKSXLYUOT-UHFFFAOYSA-N netropsin Chemical compound C1=C(C(=O)NCCC(N)=N)N(C)C=C1NC(=O)C1=CC(NC(=O)CN=C(N)N)=CN1C IDBIFFKSXLYUOT-UHFFFAOYSA-N 0.000 description 2
• 230000003546 nucleic acid damage Effects 0.000 description 2
• 150000002924 oxiranes Chemical class 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 230000008782 phagocytosis Effects 0.000 description 2
• 150000002990 phenothiazines Chemical class 0.000 description 2
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
• 239000013600 plasmid vector Substances 0.000 description 2
• 238000007747 plating Methods 0.000 description 2
• 101150114864 plcA gene Proteins 0.000 description 2
• 101150050662 plcB gene Proteins 0.000 description 2
• 108040000983 polyphosphate:AMP phosphotransferase activity proteins Proteins 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 102000004196 processed proteins & peptides Human genes 0.000 description 2
• 230000009465 prokaryotic expression Effects 0.000 description 2
• 230000002062 proliferating effect Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 238000010791 quenching Methods 0.000 description 2
• 150000007660 quinolones Chemical class 0.000 description 2
• 150000003254 radicals Chemical class 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000008263 repair mechanism Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
• 230000007480 spreading Effects 0.000 description 2
• 238000003892 spreading Methods 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 150000003463 sulfur Chemical class 0.000 description 2
• 229940021747 therapeutic vaccine Drugs 0.000 description 2
• 238000000108 ultra-filtration Methods 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• 230000001018 virulence Effects 0.000 description 2
• 238000003260 vortexing Methods 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• JVJGCCBAOOWGEO-RUTPOYCXSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-4-amino-2-[[(2s,3s)-2-[[(2s,3s)-2-[[(2s)-2-azaniumyl-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumy Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 JVJGCCBAOOWGEO-RUTPOYCXSA-N 0.000 description 1
• WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
• LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
• SNKUSVNHTCUELQ-UHFFFAOYSA-N 2-[[4-amino-2-[[2-[[2-[2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]propanoylamino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoic aci Chemical compound CC(C)CC(C(O)=O)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(O)=O)NC(=O)C(C)NC(=O)CNC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(N)CC1=CC=C(O)C=C1 SNKUSVNHTCUELQ-UHFFFAOYSA-N 0.000 description 1
• ANDCDPBTSFSYLB-UHFFFAOYSA-N 2-cyclopropylpyrrolo[2,3-e]indole Chemical class C1CC1C(C=C1C=C2)=NC1=C1C2=NC=C1 ANDCDPBTSFSYLB-UHFFFAOYSA-N 0.000 description 1
• QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
• SWMBSMJCJWZRNR-UHFFFAOYSA-N 2-pyren-1-yloxirane Chemical compound C1OC1C1=CC=C(C=C2)C3=C4C2=CC=CC4=CC=C13 SWMBSMJCJWZRNR-UHFFFAOYSA-N 0.000 description 1
• BTQAFTBKHVLPEV-UHFFFAOYSA-N 3h-naphtho[2,3-e]indazole Chemical class C1=CC=CC2=CC3=C4C=NNC4=CC=C3C=C21 BTQAFTBKHVLPEV-UHFFFAOYSA-N 0.000 description 1
• DWAOUXYZOSPAOH-UHFFFAOYSA-N 4-[2-(diethylamino)ethoxy]furo[3,2-g]chromen-7-one;hydrochloride Chemical group [Cl-].O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC[NH+](CC)CC DWAOUXYZOSPAOH-UHFFFAOYSA-N 0.000 description 1
• JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 1
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
• 101710166488 6 kDa early secretory antigenic target Proteins 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• 229930195730 Aflatoxin Natural products 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 244000153158 Ammi visnaga Species 0.000 description 1
• 235000010585 Ammi visnaga Nutrition 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• 102000052587 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Human genes 0.000 description 1
• 108700004606 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Proteins 0.000 description 1
• 241001465677 Ancylostomatoidea Species 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 description 1
• 241000712892 Arenaviridae Species 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 101150076489 B gene Proteins 0.000 description 1
• 208000004429 Bacillary Dysentery Diseases 0.000 description 1
• 241000034280 Bacillus anthracis str. Sterne Species 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
• FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 241000588807 Bordetella Species 0.000 description 1
• 241000589968 Borrelia Species 0.000 description 1
• 241000589969 Borreliella burgdorferi Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 102100029894 Bromodomain testis-specific protein Human genes 0.000 description 1
• 241001148106 Brucella melitensis Species 0.000 description 1
• 108010077333 CAP1-6D Proteins 0.000 description 1
• SNKUSVNHTCUELQ-UOGODTEOSA-N CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SNKUSVNHTCUELQ-UOGODTEOSA-N 0.000 description 1
• 102100035793 CD83 antigen Human genes 0.000 description 1
• 101150108242 CDC27 gene Proteins 0.000 description 1
• AUJXLBOHYWTPFV-BLWRDSOESA-N CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1 Chemical compound CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1 AUJXLBOHYWTPFV-BLWRDSOESA-N 0.000 description 1
• 101100447914 Caenorhabditis elegans gab-1 gene Proteins 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 235000001258 Cinchona calisaya Nutrition 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
• 108010061982 DNA Ligases Proteins 0.000 description 1
• 102000012410 DNA Ligases Human genes 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 230000001482 DNA photocleavage Effects 0.000 description 1
• 230000008265 DNA repair mechanism Effects 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 108010046331 Deoxyribodipyrimidine photo-lyase Proteins 0.000 description 1
• 102100040606 Dermatan-sulfate epimerase Human genes 0.000 description 1
• 101710127030 Dermatan-sulfate epimerase Proteins 0.000 description 1
• 101100216227 Dictyostelium discoideum anapc3 gene Proteins 0.000 description 1
• 102100037070 Doublecortin domain-containing protein 2 Human genes 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
• 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
• 108010009858 Echinomycin Proteins 0.000 description 1
• 108010000912 Egg Proteins Proteins 0.000 description 1
• 102000002322 Egg Proteins Human genes 0.000 description 1
• CTSPAMFJBXKSOY-UHFFFAOYSA-N Ellipticine Natural products N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical class C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
• 241000713800 Feline immunodeficiency virus Species 0.000 description 1
• 108090000382 Fibroblast growth factor 6 Proteins 0.000 description 1
• 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 1
• 208000001640 Fibromyalgia Diseases 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000589601 Francisella Species 0.000 description 1
• 102100039717 G antigen 1 Human genes 0.000 description 1
• 102100039699 G antigen 4 Human genes 0.000 description 1
• 102100039698 G antigen 5 Human genes 0.000 description 1
• 101710092267 G antigen 5 Proteins 0.000 description 1
• 102100039713 G antigen 6 Human genes 0.000 description 1
• 101710092269 G antigen 6 Proteins 0.000 description 1
• 241000531123 GB virus C Species 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
• 241000224466 Giardia Species 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 206010018612 Gonorrhoea Diseases 0.000 description 1
• ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 108010006464 Hemolysin Proteins Proteins 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 208000005331 Hepatitis D Diseases 0.000 description 1
• 241000724675 Hepatitis E virus Species 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
• 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
• 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
• 101000794028 Homo sapiens Bromodomain testis-specific protein Proteins 0.000 description 1
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 1
• 101000954709 Homo sapiens Doublecortin domain-containing protein 2 Proteins 0.000 description 1
• 101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
• 101000886678 Homo sapiens G antigen 2D Proteins 0.000 description 1
• 101000886136 Homo sapiens G antigen 4 Proteins 0.000 description 1
• 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 description 1
• 101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 description 1
• 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 description 1
• 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
• 101001036689 Homo sapiens Melanoma-associated antigen B5 Proteins 0.000 description 1
• 101001036675 Homo sapiens Melanoma-associated antigen B6 Proteins 0.000 description 1
• 101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 description 1
• 101001057159 Homo sapiens Melanoma-associated antigen C3 Proteins 0.000 description 1
• 101001133081 Homo sapiens Mucin-2 Proteins 0.000 description 1
• 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
• 101001109419 Homo sapiens RNA-binding protein NOB1 Proteins 0.000 description 1
• 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 description 1
• 101000821981 Homo sapiens Sarcoma antigen 1 Proteins 0.000 description 1
• 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000648075 Homo sapiens Trafficking protein particle complex subunit 1 Proteins 0.000 description 1
• 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 101710123134 Ice-binding protein Proteins 0.000 description 1
• 101710082837 Ice-structuring protein Proteins 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 101710198693 Invasin Proteins 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 241000234435 Lilium Species 0.000 description 1
• 206010024641 Listeriosis Diseases 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 108010010995 MART-1 Antigen Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
• 102000000440 Melanoma-associated antigen Human genes 0.000 description 1
• 108050008953 Melanoma-associated antigen Proteins 0.000 description 1
• 102100039475 Melanoma-associated antigen B5 Human genes 0.000 description 1
• 102100039483 Melanoma-associated antigen B6 Human genes 0.000 description 1
• 102100027252 Melanoma-associated antigen C2 Human genes 0.000 description 1
• 102100027248 Melanoma-associated antigen C3 Human genes 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• 102100034263 Mucin-2 Human genes 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
• 241000186359 Mycobacterium Species 0.000 description 1
• 102000003505 Myosin Human genes 0.000 description 1
• 108060008487 Myosin Proteins 0.000 description 1
• WNYOPINACXXCOV-BCAICVSZSA-N N-[(4S,7R,11S,17S,20R,24S)-2,4,12,15,17,25-hexamethyl-11,24-bis[(2R)-3-methylbutan-2-yl]-27-methylsulfanyl-3,6,10,13,16,19,23,26-octaoxo-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide Chemical compound CSC1SCC2N(C)C(=O)[C@H](C)NC(=O)[C@@H](COC(=O)[C@H]([C@H](C)C(C)C)N(C)C(=O)C1N(C)C(=O)[C@H](C)NC(=O)[C@@H](COC(=O)[C@H]([C@H](C)C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1 WNYOPINACXXCOV-BCAICVSZSA-N 0.000 description 1
• AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108010042309 Netropsin Proteins 0.000 description 1
• 241000243985 Onchocerca volvulus Species 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 108700006640 OspA Proteins 0.000 description 1
• 206010033078 Otitis media Diseases 0.000 description 1
• 229940123973 Oxygen scavenger Drugs 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102000036673 PRAME Human genes 0.000 description 1
• 108060006580 PRAME Proteins 0.000 description 1
• 239000002033 PVDF binder Substances 0.000 description 1
• 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
• 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 201000011152 Pemphigus Diseases 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 229940122985 Peptide agonist Drugs 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 241000150350 Peribunyaviridae Species 0.000 description 1
• 102000015439 Phospholipases Human genes 0.000 description 1
• 108010064785 Phospholipases Proteins 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 241000224017 Plasmodium berghei Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102000029797 Prion Human genes 0.000 description 1
• 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 description 1
• WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
• 101710194807 Protective antigen Proteins 0.000 description 1
• 102100022491 RNA-binding protein NOB1 Human genes 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 102000018120 Recombinases Human genes 0.000 description 1
• 108010091086 Recombinases Proteins 0.000 description 1
• 241000702247 Reoviridae Species 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
• SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 1
• 101000999689 Saimiriine herpesvirus 2 (strain 11) Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
• 206010039438 Salmonella Infections Diseases 0.000 description 1
• 102100021466 Sarcoma antigen 1 Human genes 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 102100038689 Scm-like with four MBT domains protein 1 Human genes 0.000 description 1
• 244000000231 Sesamum indicum Species 0.000 description 1
• 206010040550 Shigella infections Diseases 0.000 description 1
• 241000607758 Shigella sp. Species 0.000 description 1
• 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 description 1
• 101710185775 Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 description 1
• 241001147693 Staphylococcus sp. Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical class [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 108010002687 Survivin Proteins 0.000 description 1
• 101100029707 Synechocystis sp. (strain PCC 6803 / Kazusa) phrA gene Proteins 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 239000008049 TAE buffer Substances 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
• 241000710924 Togaviridae Species 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 102100025256 Trafficking protein particle complex subunit 1 Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 206010044608 Trichiniasis Diseases 0.000 description 1
• 101150046432 Tril gene Proteins 0.000 description 1
• GULVULFEAVZHHC-IITWSDOJSA-N Triostin A Chemical compound O=C([C@@H]1CSSC[C@H](N(C(=O)[C@H](C)NC2=O)C)C(=O)N(C)[C@H](C(OC[C@H](C(=O)N[C@@H](C)C(=O)N1C)NC(=O)C=1N=C3C=CC=CC3=NC=1)=O)C(C)C)N(C)[C@@H](C(C)C)C(=O)OC[C@H]2NC(=O)C1=CN=C(C=CC=C2)C2=N1 GULVULFEAVZHHC-IITWSDOJSA-N 0.000 description 1
• LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
• 101710107540 Type-2 ice-structuring protein Proteins 0.000 description 1
• 208000037386 Typhoid Diseases 0.000 description 1
• 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 description 1
• 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 description 1
• VGQOVCHZGQWAOI-UHFFFAOYSA-N UNPD55612 Natural products N1C(O)C2CC(C=CC(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-UHFFFAOYSA-N 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 101150063325 ab gene Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
• HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical class C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 description 1
• 229930183665 actinomycin Natural products 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 239000005409 aflatoxin Substances 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 230000002152 alkylating effect Effects 0.000 description 1
• 208000030961 allergic reaction Diseases 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 244000037640 animal pathogen Species 0.000 description 1
• 150000001454 anthracenes Chemical class 0.000 description 1
• VGQOVCHZGQWAOI-HYUHUPJXSA-N anthramycin Chemical compound N1[C@@H](O)[C@@H]2CC(\C=C\C(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-HYUHUPJXSA-N 0.000 description 1
• 229960005447 anthrax vaccines Drugs 0.000 description 1
• 230000001745 anti-biotin effect Effects 0.000 description 1
• 230000005809 anti-tumor immunity Effects 0.000 description 1
• 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
• 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 150000001541 aziridines Chemical class 0.000 description 1
• XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
• ZAPZRSTXADAUHS-UHFFFAOYSA-N benzanthracene-5,6-oxide Chemical compound C12=CC3=CC=CC=C3C=C2C2=CC=CC=C2C2=C1O2 ZAPZRSTXADAUHS-UHFFFAOYSA-N 0.000 description 1
• BLFXIWBKUAIZSP-UHFFFAOYSA-N benzo[l]pyrene-7,8-diol Chemical compound C1=CC=C2C3=CC=CC=C3C3=C(O)C(O)=CC4=CC=C1C2=C43 BLFXIWBKUAIZSP-UHFFFAOYSA-N 0.000 description 1
• 150000001565 benzotriazoles Chemical class 0.000 description 1
• HINUXGZHCXYZMB-DJNFHWKQSA-N beta-Rhodomycin Chemical compound O([C@H]1C[C@]([C@@H](C2=C(O)C=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C21)O)(O)CC)[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1 HINUXGZHCXYZMB-DJNFHWKQSA-N 0.000 description 1
• 229930182873 beta-Rhodomycin Natural products 0.000 description 1
• 239000007621 bhi medium Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
• 229940038698 brucella melitensis Drugs 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 150000003857 carboxamides Chemical class 0.000 description 1
• JGPOSNWWINVNFV-UHFFFAOYSA-N carboxyfluorescein diacetate succinimidyl ester Chemical compound C=1C(OC(=O)C)=CC=C2C=1OC1=CC(OC(C)=O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O JGPOSNWWINVNFV-UHFFFAOYSA-N 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 229960003677 chloroquine Drugs 0.000 description 1
• WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
• ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
• 229960001076 chlorpromazine Drugs 0.000 description 1
• 229910052804 chromium Inorganic materials 0.000 description 1
• 239000011651 chromium Substances 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 210000001728 clone cell Anatomy 0.000 description 1
• 206010009887 colitis Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007402 cytotoxic response Effects 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 238000007872 degassing Methods 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 229940029030 dendritic cell vaccine Drugs 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 239000012470 diluted sample Substances 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• OKQSSSVVBOUMNZ-UHFFFAOYSA-N diminazene diaceturate Chemical compound CC(=O)NCC(O)=O.CC(=O)NCC(O)=O.C1=CC(C(=N)N)=CC=C1NN=NC1=CC=C(C(N)=N)C=C1 OKQSSSVVBOUMNZ-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 230000005782 double-strand break Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• QCUPYFTWJOZAOB-HYXAFXHYSA-N ectylurea Chemical compound CC\C(=C\C)C(=O)NC(N)=O QCUPYFTWJOZAOB-HYXAFXHYSA-N 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 125000004072 flavinyl group Chemical group 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 150000002220 fluorenes Chemical class 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 229940124307 fluoroquinolone Drugs 0.000 description 1
• 210000000285 follicular dendritic cell Anatomy 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 231100000118 genetic alteration Toxicity 0.000 description 1
• 230000004077 genetic alteration Effects 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 208000001786 gonorrhea Diseases 0.000 description 1
• 229940047650 haemophilus influenzae Drugs 0.000 description 1
• 125000001475 halogen functional group Chemical group 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 230000009083 hemolysis by symbiont of host erythrocytes Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 208000029570 hepatitis D virus infection Diseases 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 229940031689 heterologous vaccine Drugs 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
• 150000002460 imidazoles Chemical class 0.000 description 1
• 230000008076 immune mechanism Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000005732 intercellular adhesion Effects 0.000 description 1
• 210000005133 interdigitating dendritic cell Anatomy 0.000 description 1
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
• 230000001678 irradiating effect Effects 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 210000002664 langerhans' cell Anatomy 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 231100000225 lethality Toxicity 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 229940124590 live attenuated vaccine Drugs 0.000 description 1
• 229940023012 live-attenuated vaccine Drugs 0.000 description 1
• 208000037841 lung tumor Diseases 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 101710130522 mRNA export factor Proteins 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 229960000901 mepacrine Drugs 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
• 229960000907 methylthioninium chloride Drugs 0.000 description 1
• 238000012737 microarray-based gene expression Methods 0.000 description 1
• 210000000274 microglia Anatomy 0.000 description 1
• 238000001000 micrograph Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 235000013923 monosodium glutamate Nutrition 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 208000002042 onchocerciasis Diseases 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 229940126578 oral vaccine Drugs 0.000 description 1
• AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000007918 pathogenicity Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 201000001976 pemphigus vulgaris Diseases 0.000 description 1
• 229940056360 penicillin g Drugs 0.000 description 1
• 229940023041 peptide vaccine Drugs 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 150000002988 phenazines Chemical class 0.000 description 1
• 125000001644 phenoxazinyl group Chemical class C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
• 229960005323 phenoxyethanol Drugs 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 101150011693 phr gene Proteins 0.000 description 1
• INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
• 230000007505 plaque formation Effects 0.000 description 1
• 238000013492 plasmid preparation Methods 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920000768 polyamine Polymers 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 230000002516 postimmunization Effects 0.000 description 1
• 210000004986 primary T-cell Anatomy 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 229960000286 proflavine Drugs 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 229940021993 prophylactic vaccine Drugs 0.000 description 1
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 150000003233 pyrroles Chemical class 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000000171 quenching effect Effects 0.000 description 1
• GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
• 229960000948 quinine Drugs 0.000 description 1
• 150000003248 quinolines Chemical class 0.000 description 1
• 229930183794 quinomycin Natural products 0.000 description 1
• 108700038839 quinomycin Proteins 0.000 description 1
• AUJXLBOHYWTPFV-UHFFFAOYSA-N quinomycin A Natural products CN1C(=O)C(C)NC(=O)C(NC(=O)C=2N=C3C=CC=CC3=NC=2)COC(=O)C(C(C)C)N(C)C(=O)C2N(C)C(=O)C(C)NC(=O)C(NC(=O)C=3N=C4C=CC=CC4=NC=3)COC(=O)C(C(C)C)N(C)C(=O)C1CSC2SC AUJXLBOHYWTPFV-UHFFFAOYSA-N 0.000 description 1
• 150000003252 quinoxalines Chemical class 0.000 description 1
• 108010014186 ras Proteins Proteins 0.000 description 1
• 239000012429 reaction media Substances 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 239000002151 riboflavin Substances 0.000 description 1
• 229960002477 riboflavin Drugs 0.000 description 1
• 235000019192 riboflavin Nutrition 0.000 description 1
• 235000002020 sage Nutrition 0.000 description 1
• 206010039447 salmonellosis Diseases 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 201000005113 shigellosis Diseases 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 230000005783 single-strand break Effects 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000000638 solvent extraction Methods 0.000 description 1
• 229940063673 spermidine Drugs 0.000 description 1
• 229940063675 spermine Drugs 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 229940031626 subunit vaccine Drugs 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• 150000005075 thioxanthenes Chemical class 0.000 description 1
• 241001147422 tick-borne encephalitis virus group Species 0.000 description 1
• 150000004992 toluidines Chemical class 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 239000001003 triarylmethane dye Substances 0.000 description 1
• 208000003982 trichinellosis Diseases 0.000 description 1
• 201000007588 trichinosis Diseases 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
• 201000002311 trypanosomiasis Diseases 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000037455 tumor specific immune response Effects 0.000 description 1
• 201000008297 typhoid fever Diseases 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 239000012646 vaccine adjuvant Substances 0.000 description 1
• 229940124931 vaccine adjuvant Drugs 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 244000000057 wild-type pathogen Species 0.000 description 1
• 125000001834 xanthenyl group Chemical class C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
• 229940118695 yersinia pestis Drugs 0.000 description 1